Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Clinical Therapeutics|July 15, 1998
An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study InvestigatorsS Oparil, R Guthrie, A J Lewin, et al.
European Journal of Clinical Pharmacology|June 15, 2000
Influence of renal function on the pharmacokinetics of cerivastatin in normocholesterolemic adultsA L Mazzu, J T Lettieri, E Kelly, et al.
Clinical Therapeutics|January 28, 1998
Comparative efficacy and tolerability of two long-acting calcium antagonists, mibefradil and amlodipine, in essential hypertension. Mibefradil Hypertension Study GroupF E Karch, R Pordy, J R Benz, et al.
The American Journal of Medicine|September 1, 1977
Chronic renal vein thrombosisR Cade, G Spooner, L Juncos, et al.
Journal of Viral Hepatitis|July 18, 2015
A phase 1, randomized, dose-ranging study of GS-5816, a once-daily NS5A inhibitor, in patients with genotype 1-4 hepatitis C virusE Lawitz, B Freilich, J Link, et al.
Journal of Human Hypertension|August 1, 1994
Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertensionW D Hall, M A Weber, K Ferdinand, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 7, 1998
Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patientsD I Goldberg, M A Dillon, E A Slatopolsky, et al.
American Journal of Therapeutics|December 1, 1996
Safety and Efficacy of Once-Daily Captopril Plus Hydrochlorothiazide versus Nifedipine Gastrointestinal Therapeutic System in Black Patients with Mild to Moderate HypertensionM. R. Weir, D. Sugimoto, J. Gray, et al.
Journal of Viral Hepatitis|March 10, 2016
GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 studyM Rodriguez-Torres, S Glass, J Hill, et al.
Pageof 2